Unveiling the Metabolic Effects of Glycomacropeptide
For many years, the main nitrogen source for patients with phenylketonuria (PKU) was phenylalanine-free amino acid supplements. Recently, casein glycomacropeptide (GMP) supplements have been prescribed due to its functional and sensorial properties. Nevertheless, many doubts still persist about the...
Main Authors: | Maria João Pena, Raquel Costa, Ilda Rodrigues, Sandra Martins, João Tiago Guimarães, Ana Faria, Conceição Calhau, Júlio César Rocha, Nuno Borges |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/18/9731 |
Similar Items
-
The Use of Glycomacropeptide in Patients with Phenylketonuria: A Systematic Review and Meta-Analysis
by: Maria João Pena, et al.
Published: (2018-11-01) -
The Impact of the Use of Glycomacropeptide on Satiety and Dietary Intake in Phenylketonuria
by: Anne Daly, et al.
Published: (2020-09-01) -
Continuous use of glycomacropeptide in the nutritional management of patients with phenylketonuria: a clinical perspective
by: Maria João Pena, et al.
Published: (2021-02-01) -
Preliminary Investigation to Review If a Glycomacropeptide Compared to L-Amino Acid Protein Substitute Alters the Pre- and Postprandial Amino Acid Profile in Children with Phenylketonuria
by: Anne Daly, et al.
Published: (2020-08-01) -
Dietary management of maternal phenylketonuria with glycomacropeptide and amino acids supplements: A case report
by: A. Pinto, et al.
Published: (2017-12-01)